Skip to main content
. 2021 Oct 26;12(22):2252–2265. doi: 10.18632/oncotarget.28083

Table 2. Number of AEs (number of patients, pts) by grade, where relationship to vaccine is definite, probable, or possible.

Body system Adverse event Severity scale grade All AEs
1: Mild 2: Moderate 3: Severe
AEs (pts) AEs (pts) AEs (pts)
Gastrointestinal disorders Abdominal distension 1 (1) 1 (1) 2
General disorders and
administrative site conditions
Fatigue 1 (1) 2 (2) 1 (1) 4
Injection site reaction 23 (23) 4 (3) 27
intermittent fatigue 1 (1) 2 (2) 3
Musculoskeletal and
connective tissue disorders
Musculoskeletal and connective
tissue disorders - other, sharp
pains in random spots
1 (1) 1
Nervous system disorders Headache 1 (1) 1
Intermittent headaches 1 (1) 1
Reproductive system and
breast disorders
Intermittent left breast pain 1 (1) 1
Reproductive system and breast
disorders - other, burning
sensation left breast
1 (1) 1
Vascular disorders Vascular disorders – other, night sweats 1 (1) 1
All AEs 28 (28) 12 (11) 2 (2) 42